Alder's mission is to help alleviate human suffering by generating better and safer antibody therapeutics through novel technologies. Alder plays two roles: As a biopharmaceutical company, Alder uses its proprietary technologies to uniquely identify, develop, produce and market its own antibody therapeutics. The work being done at Alder today will help those who suffer from cancer, autoimmune diseases, and inflammatory diseases. As a licensing partner, Alder is revolutionizing the way the pharmaceutical industry discovers, develops and produces antibody therapeutics. Through various licensing agreements, Alder has used its proprietary technology to help major biopharmaceutical partners advance novel therapeutics to the clinic in less time and at lower cost. Alder's licensing strategy also includes identifying strategic partners to assist in the development and marketing of its preclinical and clinical pipeline programs.
Sector:
Health Technology
Industry:
Biotechnology
Employees:
Frequently Asked Questions
What is Market Cap of Alder BioPharmaceuticals Inc?
Market cap, also known as market capitalization, is the total market value of a company. It’s calculated by multiplying the current market price by the total number of shares outstanding. Alder BioPharmaceuticals Inc market cap is N/A.
What is the 52-week high for Alder BioPharmaceuticals Inc?
52 week high is the highest price of a stock in the past 52 weeks, or one year. Alder BioPharmaceuticals Inc 52 week high is N/A as of September 07, 2025.
What is the 52-week low for Alder BioPharmaceuticals Inc?
52 week low is the lowest price of a stock in the past 52 weeks, or one year. Alder BioPharmaceuticals Inc 52 week low is N/A as of September 07, 2025.
What was Alder BioPharmaceuticals Inc stock price yesterday?
Alder BioPharmaceuticals Inc stock price yesterday was $18.88.
What is the PE ratio of Alder BioPharmaceuticals Inc?
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It’s calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company’s Market Cap by the Net Profit. Alder BioPharmaceuticals Inc’s P/E ratio is None.
What is the Price-to-Book ratio of Alder BioPharmaceuticals Inc?
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It’s calculated by dividing a company’s market capitalization by its book value. Alder BioPharmaceuticals Inc P/B ratio is None.
What is Alder BioPharmaceuticals Inc's EBITDA?
EBITDA is a widely used measure of corporate profitability. It stands for Earnings before Interest, Taxes, Depreciation, and Amortization. It attempts to reflect the cash profit generated by a company’s operations. Alder BioPharmaceuticals Inc's EBITDA is -2.77.
What is the 50-day moving average of Alder BioPharmaceuticals Inc?
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It’s calculated by averaging the closing stock price over the previous 50 trading days. Alder BioPharmaceuticals Inc 50-day moving average is N/A.
How many employess does Alder BioPharmaceuticals Inc has?
